Selegiline
- 1 May 1991
- journal article
- clinical trial
- Published by Springer Nature in Drugs & Aging
- Vol. 1 (3), 228-248
- https://doi.org/10.2165/00002512-199101030-00006
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- (−) deprenyl induces activities of both superoxide dismutase and catalase but not of glutathione peroxidase in the striatum of young male ratsLife Sciences, 1991
- Deprenyl for the Treatment of Early Parkinson's DiseaseNew England Journal of Medicine, 1990
- Selegiline and Parkinson??s DiseaseDrugs, 1990
- PergolideDrugs, 1990
- Effect of Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1989
- Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patientsNeuroscience Letters, 1986
- Glutathione peroxidase activity in Parkinson's disease brainNeuroscience Letters, 1985
- Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm studyJournal of Neural Transmission, 1985
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidaseBiochemical and Biophysical Research Communications, 1984
- The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenilJournal of Neural Transmission, 1975